Could Cell Transplants One Day Restore Vision in Glaucoma? A New Study Looks at One Major Roadblock

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/could-cell-transplants-one-day-restore-vision-in-glaucoma-a-new-study-looks-at-one-major-roadblock

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Could Cell Transplants One Day Restore Vision in Glaucoma? A New Study Looks at One Major RoadblockGlaucoma is a leading cause of permanent blindness. In glaucoma, retinal ganglion cells (RGCs) die off over time. These RGCs are special nerve cells in the eye that receive signals from light-detecting cells and carry them through the optic nerve to the brain () (). When these ganglion cells are lost, the visual signals can’t reach the brain, and vision is irreversibly damaged. Unfortunately, adult eyes cannot naturally regrow these lost nerve cells, so once vision is gone it’s gone for good () (). Scientists have long dreamed of replacing lost RGCs by transplanting new cells into the retina. If new ganglion cells could be made to survive and connect correctly, they might restore vision in people with advanced glaucoma. A promising source of new cells is stem cells – for example, skin or blood cells from a patient can be reprogrammed into stem cells, and then coaxed in the lab to become new RGCs. In fact, researchers note that developing lab-grown RGCs “holds the potential to some day make possible the restoration of vision” for people who have lost it (). However, this goal has always faced very big challenges. Retinal Ganglion Cells and GlaucomaRetinal ganglion cells are essentially the final output cells of the retina. They collect and bundle up visual information from the retina’s photoreceptors and interneurons, then send that information along their long axons through the optic nerve to the brain (). You can think of them as the retina’s wiring that plugs into the brain. In glaucoma, pressure or other damage causes these RGCs to slowly die off. A medical review explains that glaucoma is “characterized by selective, progressive degeneration of the retinal ganglion cells” – in other words, these cells gradually disappear over time (). Once that happens, the eye cannot send visual signals anymore and vision is lost. Importantly, mammalian RGCs do not regenerate on their own. ()Because of this, current glaucoma treatments can only slow vision loss (for example, by lowering eye pressure) – they cannot restore the lost RGC cells or recover vision that has already been lost. That is why researchers are pursuing cell replacement: the idea is to transplant healthy new RGCs into the retina to replace the dead ones. But as scientists explain, the retina of adults is not easily re-wired, which makes this very difficult.Why Replacing These Cells Is So HardTransplanting RGCs into a retina and having them work properly faces many hurdles. One big obstacle is the structure of the eye itself. The innermost surface of the retina (next to the vitreous gel inside the eye) is covered by a thin layer called the inner limiting membrane (ILM). The ILM is essentially a basement membrane that separates the retina from the eye’s interior. In simple terms, it is like a transparent inner lining on the surface of the retina (). This membrane (while important during eye development) becomes a physical barrier in the adult eye. Experts have noted that the ILM “may constitute a significant barrier to emerging ocular therapies” like gene therapy or cell transplants (). In fact, a recent r